Kristen Quigley joined Hinge Bio in early 2025 as Chief Clinical Operations Officer. Kristen has 29 years of clinical research expertise, including 26 years governing phase I-IV clinical trials and 9 years serving in executive leadership roles. She has a proven track record of building company value via commitment to evolving with organizations, functioning in long-standing senior leadership and executive roles at both biotech companies and CROs. Her disease experience includes auto-immune, renal failure, and myriad oncology indications. Kristen served in COO, SVP, and VP roles at two biotech companies, Molecular Templates, Inc. and Threshold Pharmaceuticals, prior to joining Hinge Bio. During her tenure at a large global CRO, ICON plc, she also co-directed the Nordic region and governed large trial portfolios for several clients. Ms. Quigley holds a bachelor’s degree from Washington University in St. Louis.